Cargando…
Target animal safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for cats
The safety profile of NexGard(®) Combo, a novel topical product for cats combining esafoxolaner, eprinomectin and praziquantel, for the treatment and prevention of internal and external parasites, was evaluated in kittens, in two margin-of-safety studies (Studies #1 and #2), and in an oral tolerance...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
EDP Sciences
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019570/ https://www.ncbi.nlm.nih.gov/pubmed/33812450 http://dx.doi.org/10.1051/parasite/2021015 |